What is Bio-Techne's total equity?

Bio-Techne (TECH) reported total equity of $2.09B in Q1 2026.

How has Bio-Techne's total equity changed year-over-year?

Bio-Techne's total equity increased by 3.3% year-over-year, from $2.02B to $2.09B.

What is the long-term trend for Bio-Techne's total equity?

Over 4 years (2021 to 2025), Bio-Techne's total equity has grown at a 5.3% compound annual growth rate (CAGR), from $1.56B to $1.92B.

Bio-Techne TECH Total Equity

Total Equity at other companies

Thermo Fisher ScientificTMO

$51.93B+5.2%

DanaherDHR

$52.95B+4.1%

BrukerBRKR

$2.47B+34.6%

RevvityRVTY

$7.18B-5.9%

Bio-Rad LaboratoriesBIO

$6.85B+2.6%

Agilent TechnologiesA

$7.12B+16.1%

Other financials

Income statement

See full

Revenue$311.4M-1.5%

Gross profit$208.3M-2.9%

Operating income$75.5M+95.0%

Net income$51.0M+126%

EPS (diluted)$0.32+129%

Balance sheet

See full

Cash & equivalents$209.8M+49.2%

Total debt$290.3M-31.4%

Total assets$2.6B-3.5%

Cash flow

See full

Operating cash flow$86.7M+111%

CapEx$9.1M-10.2%

Free cash flow$77.6M+150%

Valuation

See full

Market cap$9.07B-11.8%

Enterprise value$9.15B-13.6%

P/E60.6×+13.6×

P/S7.5×-1.0×

Profitability

See full

Gross margin65%-0.8pp

Operating margin14.2%-7.9pp

Net margin10.9%-6.7pp

FCF margin22.3%+4.0pp

Returns & leverage

See full

Return on equity6.5%-3.9pp

Debt / equity0.1×-0.1×

Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Techne's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Techne's total equity?: Bio-Techne (TECH) reported total equity of $2.09B in Q1 2026.
How has Bio-Techne's total equity changed year-over-year?: Bio-Techne's total equity increased by 3.3% year-over-year, from $2.02B to $2.09B.
What is the long-term trend for Bio-Techne's total equity?: Over 4 years (2021 to 2025), Bio-Techne's total equity has grown at a 5.3% compound annual growth rate (CAGR), from $1.56B to $1.92B.